# Microbial Interactions in Nature: The Impact of Gram-Negative Bacilli on the Hyphal Growth of Candida albicans

**Authors:** Madalina Adriana Bordea, Benjamin Thomas Georg Nutz, Alin-Dan Chiorean, Gabriel Samasca, Iulia Lupan, Laura Mihaela Simon, Lia Pepelea

PMC · DOI: 10.3390/pathogens14040327 · Pathogens · 2025-03-28

## TL;DR

This paper explores how Gram-negative bacteria affect the growth of Candida albicans, a fungus that can cause severe infections in people with weakened immune systems.

## Contribution

The study introduces a focused analysis of microbial interactions that could enhance fungal virulence in polymicrobial infections.

## Key findings

- Gram-negative bacilli influence hyphal growth of Candida albicans.
- Polymicrobial interactions may increase disease severity in immunocompromised individuals.
- Understanding these interactions could improve clinical treatment strategies for co-infections.

## Abstract

The escalating global prevalence of fungal and bacterial co-infections underscores the significant and multifaceted impact of ubiquitous microorganisms on both environmental equilibria and human well-being. The human microbiome, a complex ecosystem of bacterial communities, harbors opportunistic pathogens capable of inducing superinfections or concurrent infections with Candida spp. The intricate interplay, exemplified by the interaction between Candida albicans and diverse bacteria, necessitates rigorous investigation to elucidate mechanisms by which this polymicrobial behavior potentiates fungal virulence, particularly in immunocompromised individuals. Our study aims to comprehensively examine the ramifications of these interactions, with a specific focus on their influence on fungal virulence and the consequent exacerbation of disease severity. Achieving a comprehensive understanding of these complex relationships is paramount for informing effective clinical management strategies for infectious diseases, and the accurate identification of fungal–bacterial co-infections holds substantial implications for optimizing clinical treatment paradigms, especially in vulnerable immunocompromised hosts.

## Linked entities

- **Species:** Candida albicans (taxon 5476)

## Full-text entities

- **Diseases:** bacterial co-infections (MESH:D060085), fungal (MESH:D009181), infections (MESH:D007239), infectious diseases (MESH:D003141)
- **Species:** Homo sapiens (human, species) [taxon 9606], Candida albicans (species) [taxon 5476]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12030758/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12030758/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12030758/full.md

---
Source: https://tomesphere.com/paper/PMC12030758